Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy
Research output: Contribution to journal › Article › peer-review
39Scopus
citations
Fingerprint
Dive into the research topics of 'Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy'. Together they form a unique fingerprint.